Using a systematic approach we:
- Design novel chemo-enzymatic routes to small molecules e.g. pharmaceuticals, fine chemicals, food/drink ingredients, beauty care products
- Apply our organic chemistry expertise to synthesise substrates, pathway intermediates, cofactors, analytical reference standards for use in bioprocess development and optimisation
- Deliver validated analytical methods suitable for final product characterisation, in-process analysis and release testing
- Monitor, identify and address bioprocess/pathway rate limitations
- Design, develop, optimise and validate new assays and/or pre-defined assays for specific targets
- Employ high-throughput screening technologies for hit-to-lead identification
- Efficiently recover and purify fully active target molecules from biological sample matrices to meet product specification criteria
— Professor George Hanna, Director, NIHR Diagnostic Evidence Co-operative and Head of Surgery, St. Mary’s Hospital, Paddington, London“Ingenza’s simple diagnostic assay for confirming nasogastric (NG) tube placement is an easy-to-implement and low cost option, providing a highly specific and sensitive test with the potential to reduce the number of expensive chest X-rays.”